Study of pitavastatin 1 mg vs. pravastatin 10 mg, pitavastatin 2 mg vs. pravastatin 20 mg and pitavastatin 4 mg vs. pravastatin 40 mg (following up-titration) in elderly patients with primary hypercholesterolemia or combined dyslipidemia.
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2012
At a glance
- Drugs Pitavastatin (Primary) ; Pravastatin (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Kowa
- 01 Sep 2010 Results presented at the ESC Congress 2010: Annual Congress of the European Society of Cardiology.
- 29 Aug 2010 Extension study results presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.
- 29 Aug 2010 Results presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History